Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding osteoporosis.

R Marcus1

  • 1Geriatric Research, Education and Clinical Center, Veterans Affairs Medical Center, Palo Alto 94304.

The Western Journal of Medicine
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Understanding bone mass regulation has advanced, revealing age-related bone loss involves architectural changes, not just quantity. Restoring bone quality with biotechnology, like growth factors, offers future osteoporosis treatment hope.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What do South African adolescents want in a sexual health service? Evidence from the South African Studies on HIV in Adolescents (SASHA) project.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018
Same author

Comments on Galli et al.: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.

Bone marrow transplantation·2017
Same author

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

Leukemia & lymphoma·2016
Same author

Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.

International journal of clinical practice·2014
Same author

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
See all related articles

Area of Science:

  • Bone biology and osteoporosis research.

Background:

  • Age-related bone loss involves decreased bone mass, increased cortical porosity, and loss of trabecular connections.
  • Bone strength is determined by both architectural and material properties, making bone quantity an insufficient predictor of fracture risk.

Purpose of the Study:

  • To review recent progress in understanding bone mass regulation.
  • To discuss the limitations of traditional osteoporosis therapies.
  • To explore the potential of modern biotechnology for restoring bone quantity and quality.

Main Methods:

  • Review of recent scientific literature on bone biology and osteoporosis.
  • Analysis of the mechanisms of age-related bone loss.
  • Evaluation of current and emerging therapeutic strategies for osteoporosis.

Related Experiment Videos

Main Results:

  • Bone loss is a complex process affecting bone architecture, not just overall mass.
  • Estrogen therapy effectively reduces fracture risk but restoring bone quantity and quality pharmacologically remains a challenge.

Conclusions:

  • Further research into bone architecture and material properties is crucial for precise fracture risk assessment.
  • Modern biotechnology, including growth factors and osteotropic compounds, holds promise for developing novel osteoporosis treatments that restore bone quality.